sodium phenylbutyrate / Generic mfg.  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

4 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sodium phenylbutyrate / Generic mfg.
NCT01784718: Buphenyl Therapy for Byler's Disease

No Longer Available
N/A
US
Buphenyl
University of Pittsburgh
Byler Disease
 
 
NCT01949766: Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease

No Longer Available
N/A
US
Glycerol phenylbutyrate, RAVICTI
University of Pittsburgh
Byler Disease
 
 
NCT05028803: The Effects of Sodium Phenylbutyrate on Circulating Branched Chain Amino Acids

Recruiting
N/A
6
Europe
sodium phenylbutyrate
University of Nottingham
Obese Non Diabetic
09/22
03/23
ChiCTR2100051913: Sodium Phenylbutyrate Granules Combined with Tauroursodeoxycholic Acid Capsules for Amyotrophic Lateral Sclerosis: A Multicentre, Randomised, Double-blind, Placebo-controlled Clinical Trial

Not yet recruiting
N/A
204
 
Sodium phenylbutyrate granules + tauroursodeoxycholic acid capsules ;Sodium phenylbutyrate placebo + tauroursodeoxycholic acid placebo
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Zhaoke Pharmaceutical (Guangzhou) Co., Ltd.
Amyotrophic lateral sclerosis
 
 

Download Options